Catalyst Wire Dossier Catalyst Wire Dossier

Favipiravir (Favipira)

Favipiravir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Favipiravir (Favipira), covering 2020-05-26 to 2020-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh [Phase 2, Phase 3]

See pricing